Autolus Therapeutics (FRA:6A3A) Total Liabilities : €315.82 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Total Liabilities?

Autolus Therapeutics's Total Liabilities for the quarter that ended in Sep. 2024 was €315.82 Mil.

Autolus Therapeutics's quarterly Total Liabilities increased from Mar. 2024 (€293.85 Mil) to Jun. 2024 (€302.65 Mil) and increased from Jun. 2024 (€302.65 Mil) to Sep. 2024 (€315.82 Mil).

Autolus Therapeutics's annual Total Liabilities increased from Dec. 2021 (€81.63 Mil) to Dec. 2022 (€180.87 Mil) and increased from Dec. 2022 (€180.87 Mil) to Dec. 2023 (€242.00 Mil).

Autolus Therapeutics Total Liabilities Historical Data

The historical data trend for Autolus Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Total Liabilities Chart

Autolus Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

43.83

69.22

81.63

180.87

242.00

Autolus Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															211.37	242.00	293.85	302.65	315.82

Autolus Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Autolus Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	41.024	+	(43.937	+	157.042
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	242.00

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	344.224	-	102.222
	=	242.00

Autolus Therapeutics's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	47.279	+	(43.844	+	224.7
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	315.82

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	745.568	-	429.745
	=	315.82

Autolus Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Autolus Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (FRA:6A3A) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

AUTL:USA

Address

191 Wood Lane, The MediaWorks, London, GBR, W12 7FP

Website

https://www.autolus.com

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Autolus Therapeutics Headlines

No Headlines